-- 根據FactSet調查的分析師報告,GE醫療科技(GEHC)的平均評級為“增持”,平均目標價為80.88美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)
Related Articles
Joinn Laboratories Grants 1.4 Million Award Shares Under 2022 Scheme
Joinn Laboratories (SHA:603127, HKG:6127) granted a little over 1.4 million award shares to 12 participants under a 2022 share incentive scheme, according to a Thursday Hong Kong bourse filing.Of the total, 500,00 shares were granted to Chair Feng Yuxia, with the others being offered to directors and managers of the group.
Sector Update: Financial Stocks Decline Pre-Bell Thursday
Financial stocks were declining pre-bell Thursday, with the State Street Financial Select Sector SPDR ETF (XLF) down 0.6%.The Direxion Daily Financial Bull 3X Shares (FAS) was 1.9% lower and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 1.9%.Banco Bilbao Vizcaya Argentaria (BBVA) stock was up more than 2% after the company reported higher Q1 adjusted earnings and gross income.ING Groep (ING) shares were up more than 2% after the company posted higher Q1 earnings and total income.Willis Towers Watson (WTW) stock was down more than 9% even after the company posted higher Q1 adjusted earnings and revenue.
Sector Update: Health Care Stocks Rise Premarket Thursday
Health care stocks were rising premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) up 0.6%.Eli Lilly (LLY) shares were up more than 5% after the company reported higher Q1 non-GAAP earnings and revenue, and raised its 2026 outlook.Merck (MRK) stock was down more than 1% after the company said it swung to a Q1 adjusted loss.Alnylam Pharmaceuticals (ALNY) shares were up more than 2% after the company posted higher Q1 adjusted net income and revenue.